Blocking the <scp>HIF</scp>‐1α/glycolysis axis inhibits allergic airway inflammation by reducing <scp>ILC2</scp> metabolism and function

Abstract

The HIF-1α/glycolysis axis is critical for controlling ILC2 responses in allergic airway inflammation and has potential immunotherapeutic value in asthma.